Medialization thyroplasty for cancer-related unilateral vocal fold paralysis.

Lam, Paul K Y; Ho, W K; Ng, Manwa L; Wei, William I · Otolaryngol Head Neck Surg · 2007

retrospective_cohort · Level III

Where this comes from

Abstract

To justify the application of medialization thyroplasty in Chinese patients with symptomatic cancer-related unilateral vocal fold paralysis (UVFP). Retrospective chart review from February 2000 to March 2006. Eighty-seven Chinese patients undergoing medialization thyroplasty for UVFP were included; there were no significant differences between the cancer-related and benign groups in terms of the speech and swallowing rehabilitation outcome and the perioperative complication rate (P > 0.05). The median survival time of cancer-related UVFP patients from the date of medialization to death was 129 days. Age more than 65 years was identified as the only factor for a shorter survival period after medialization (P = 0.040). Medialization thyroplasty restores satisfactory speech and swallowing and has a low perioperative complication rate in Chinese patients with cancer-related UVFP. Postmedialization survival period was also reasonable. Medialization thyroplasty is a justifiable treatment option for cancer-related UVFP.

Medical subject headings